|
Originally published In Press as doi:10.1074/jbc.M213207200 on February 14, 2003
J. Biol. Chem., Vol. 278, Issue 17, 14782-14787, April 25, 2003
Characterization of the Heparin Binding Sites in Human
Apolipoprotein E*
Hiroyuki
Saito §,
Padmaja
Dhanasekaran ,
David
Nguyen ,
Faye
Baldwin ,
Karl H.
Weisgraber¶,
Suzanne
Wehrli ,
Michael C.
Phillips , and
Sissel
Lund-Katz
From the Joseph Stokes, Jr. Research
Institute, The Children's Hospital of Philadelphia, University of
Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-4318 and the ¶ Gladstone Institute of Cardiovascular Disease,
Cardiovascular Research Institute, and Department of Pathology,
University of California, San Francisco, California 94141
Apolipoprotein (apo) E mediates lipoprotein
remnant clearance via interaction with cell-surface heparan sulfate
proteoglycans. Both the 22-kDa N-terminal domain and 10-kDa C-terminal
domain of apoE contain a heparin binding site; the N-terminal site
overlaps with the low density lipoprotein receptor binding
region and the C-terminal site is undefined. To understand the
molecular details of the apoE-heparin interaction, we defined the
microenvironments of all 12 lysine residues in intact apoE3 and
examined their relative contributions to heparin binding.
Nuclear magnetic resonance measurements showed that, in
apoE3-dimyristoyl phosphatidylcholine discs, Lys-143 and -146 in the
N-terminal domain and Lys-233 in the C-terminal domain have unusually
low pKa values, indicating high positive
electrostatic potential around these residues. Binding experiments
using heparin-Sepharose gel demonstrated that the lipid-free 10-kDa
fragment interacted strongly with heparin and a point mutation K233Q
largely abolished the binding, indicating that Lys-233 is involved in
heparin binding and that an unusually basic lysine microenvironment is
critical for the interaction with heparin. With lipidated apoE3, it is
confirmed that the Lys-233 site is completely masked and the N-terminal
site mediates heparin binding. In addition, mutations of the two
heparin binding sites in intact apoE3 demonstrated the dominant role of
the N-terminal site in the heparin binding of apoE even in the
lipid-free state. These results suggest that apoE interacts
predominately with cell-surface heparan sulfate proteoglycans through
the N-terminal binding site. However, Lys-233 may be involved in
the binding of apoE to certain cell-surface sites, such as the protein
core of biglycan.
*
This work was supported by National Institutes of Health
Grants HL56083 (to S. L. K.) and HL41633 (to K. H. W.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Present address: National Institute of Health Sciences, 1-1-43 Hoenzaka, Chuo-ku, Osaka 540-0006, Japan.
To whom correspondence should be addressed: Joseph Stokes, Jr.
Research Inst., The Children's Hospital of Philadelphia, Abramson Research Bldg., Suite 302, 3615 Civic Center Blvd., Philadelphia, PA
19104-4318. Tel.: 215-590-0588; Fax: 215-590-0583; E-mail: katzs@
email.chop.edu.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. S. Bhattacharjee, D. M. Neumann, T. P. Foster, C. Clement, G. Singh, H. W. Thompson, H. E. Kaufman, and J. M. Hill
Effective Treatment of Ocular HSK with a Human Apolipoprotein E Mimetic Peptide in a Mouse Eye Model
Invest. Ophthalmol. Vis. Sci.,
October 1, 2008;
49(10):
4263 - 4268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Kypreos, K. W. van Dijk, L. M. Havekes, and V. I. Zannis
Generation of a Recombinant Apolipoprotein E Variant with Improved Biological Functions: HYDROPHOBIC RESIDUES (LEU-261, TRP-264, PHE-265, LEU-268, VAL-269) OF apoE CAN ACCOUNT FOR THE apoE-INDUCED HYPERTRIGLYCERIDEMIA
J. Biol. Chem.,
February 25, 2005;
280(8):
6276 - 6284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Futamura, P. Dhanasekaran, T. Handa, M. C. Phillips, S. Lund-Katz, and H. Saito
Two-step Mechanism of Binding of Apolipoprotein E to Heparin: IMPLICATIONS FOR THE KINETICS OF APOLIPOPROTEIN E-HEPARAN SULFATE PROTEOGLYCAN COMPLEX FORMATION ON CELL SURFACES
J. Biol. Chem.,
February 18, 2005;
280(7):
5414 - 5422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Saito, P. Dhanasekaran, F. Baldwin, K. H. Weisgraber, M. C. Phillips, and S. Lund-Katz
Effects of Polymorphism on the Lipid Interaction of Human Apolipoprotein E
J. Biol. Chem.,
October 17, 2003;
278(42):
40723 - 40729.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|